Impact Analysis of Covid-19

The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.

Multiplexed Diagnostic Market – Market Insights

Multiplexed diagnostics are used for analysis of biological samples, which are capable of completing a screening process with a single run. Multiplexed diagnostic assays are involved in the detection and diagnosis of different diseases and infections, which include cancer, autoimmune diseases, allergies, and cardiovascular diseases. Assays performed in multiplex diagnostics include high density multiplexed assays, medium density multiplexed assays, low density multiplexed assays, and next-generation sequencing assays. Early diagnosis can minimize the risk factors associated with chronic diseases/infection and helps in proper treatment management. Moreover, multiplexed diagnostic assays have advantages such as time efficiency and high accuracy and precision, which can analyze defects and mutations in any functional biomolecules such as DNA, RNA, and protein.

The global multiplexed diagnostic market is expected to be valued at US$ 10,126.6 million in 2019 and is expected to exhibit a CAGR of 7.9% over the forecast period (2019-2027).

Figure 1. Global Multiplexed Diagnostic Market Value (US$ Mn), by Region, 2019

Multiplexed Diagnostic  | Coherent Market Insights

Source: Coherent Market Insights Analysis (2020)

Increasing incidence of disease outbreaks is expected to propel the market growth over the forecast period.

The increasing incidence of disease outbreaks such as coronavirus and Ebola virus is escalating demand for advance diagnostic measures, which is further expected to boost growth of the multiplexed diagnostic market. For instance, the coronavirus disease is the most recent outbreak, which was first reported on December 31, 2019 in Wuhan, China. According to the World Health Organization (WHO), globally 87,137 cases of the coronavirus disease were reported on 1st March 2020.

Moreover, on August 1, 2018, the Democratic Republic of the Congo Ministry of Health (DRC MoH) declared Ebola outbreak in the North Kivu province of Congo. Moreover, according to the World Health Organization (WHO), total 3,444 confirmed cases of the Ebola infection were reported on February 25, 2020, in the North Kivu province. Such incidence are expected to drive demand for high performance diagnostics, in order to prevent the false positive results of the tests and identify the pathogen accurately.

Figure 2. Global Multiplexed Diagnostic Market Share (%), by Application, 2027

Multiplexed Diagnostic  | Coherent Market Insights

Source: Coherent Market Insights Analysis (2020)

Increasing launches and approvals of new and advanced multiplexed diagnostic tools, is expected to fuel growth of the multiplexed diagnostic market.

Manufacturers are focusing on launches and approvals of innovative multiplexed diagnostics, in order to prevent false positive test results. For instance, in February 2020, Co-Diagnostics, Inc., received the CE mark for Logix Smart Coronavirus COVID-19 Test from the European Community. The Logix Smart Coronavirus COVID-19 Test kit is an in vitro diagnostic test, which operates using the real-time reverse transcriptase polymerase chain reaction (RT-PCR) process along with enhanced multiplexing for identifying the coronavirus.

Moreover, in May 2019, QIAGEN N.V. launched QIAstat-Dx syndromic testing system in the U.S. This is a multiplex molecular diagnostic system developed for the qualitative detection and identification of multiple respiratory bacterial and viral pathogens. QIAstat-Dx was launched along a comprehensive respiratory panel, which can detect over 20 pathogens.

However, limited availability of experienced and trained healthcare professionals for handling advanced multiplexed diagnostic equipment such as microarray analyzers and enzyme-linked immunosorbent assays are expected to hinder the market growth over the forecast period.

Key Players

Major players operating in the global multiplexed diagnostic market include Luminex Corporation, Thermo Fisher, Illumine Inc., Bio-Rad Laboratories, Inc., Qiagen N.V., Abbott Laboratories, Siemens Healthineers, Agilent technologies, BioMerieux SA, and F.Hoffmann-La Roche Ltd.        

The multiplexed diagnostic assay is used to identify multiple analytes in a single run cycle. Multiplex assay is used in the detection of defects such as mutation in functional biomolecules (DNA, mRNA, and protein) with the help of DNA microarray, multiplex PCR, and next-generation sequencing. In multiplexed diagnostic market, multiplexed diagnostic assay is executed in research & diagnostic laboratories, hospitals, and drug development. Moreover, this multiplexed diagnostic tool is also used in the diagnosis of various diseases, infections, drug screening, and biomarkers.

Market Dynamics

The multiplexed diagnostic market is gaining significant traction due to rising prevalence of autoimmune diseases. For instance, according to the Centers for Disease Control and Prevention (CDC), the prevalence of arthritis from 2013 to 2015 was 54 million in the U.S. adults (22.7%) and by 2040, it is expected to reach 78 million (26%) in the U.S. adults of age 18 years or above. The data represent high prevalence of autoimmune diseases, indicating the need of advance diagnostic measures, which is expected to boost growth of the multiplexed diagnostic market over the forecast period.

Key features of the study:

  • This report provides in-depth analysis of the global multiplexed diagnostic market and provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2019–2027), considering 2018 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends,  regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global multiplexed diagnostic market based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
  • Key companies covered as a part of this study include Luminex Corporation, Thermo Fisher, Illumine Inc., Bio-Rad Laboratories, Inc., Qiagen N.V., Abbott Laboratories, Siemens Healthineers, Agilent technologies, BioMerieux SA, and F.Hoffmann-La Roche Ltd.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, product type up-gradation, market expansion, and marketing tactics
  • The global multiplexed diagnostic market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global multiplexed diagnostic market

Detailed Segmentation:

  • Global Multiplexed Diagnostic Market, By Product Type:
    • Reagents & Consumables
    • Instruments
  • Global Multiplexed Diagnostic Market, By Application:
    • Disease Diagnostics
    • Molecular Diagnostics
    • Drug Development
  • Global Multiplexed Diagnostic Market, By End User:
    • Hospitals
    • Clinical Laboratories
    • Academic & Research Institutes
    • Others
  •  Global Multiplexed Diagnostic Market, By Region:
    • North America
      • By Product Type:
        • Reagents & Consumables
        • Instruments
      • By Application:
        • Disease Diagnostics
        • Molecular Diagnostics
        • Drug Development
      • By End User:
        • Hospitals
        • Clinical Laboratories
        • Academic & Research Institutes
        • Others
      • By Country:
        • U.S.
        • Canada
    • Latin America
      • By Product Type:
        • Reagents & Consumables
        • Instruments
      • By Application:
        • Disease Diagnostics
        • Molecular Diagnostics
        • Drug Development
      • By End User:
        • Hospitals
        • Clinical Laboratories
        • Academic & Research Institutes
        • Others
      • By Country:
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe
      • By Product Type:
        • Reagents & Consumables
        • Instruments
      • By Application:
        • Disease Diagnostics
        • Molecular Diagnostics
        • Drug Development
      • By End User:
        • Hospitals
        • Clinical Laboratories
        • Academic & Research Institutes
        • Others
      • By Country:
        • Germany
        • U.K.
        • France
        • Italy
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • By Product Type:
        • Reagents & Consumables
        • Instruments
      • By Application:
        • Disease Diagnostics
        • Molecular Diagnostics
        • Drug Development
      • By End User:
        • Hospitals
        • Clinical Laboratories
        • Academic & Research Institutes
        • Others
      • By Country:
        • China
        • India
        • Japan
        • Australia
        • South Korea
        • ASEAN
        • Rest of Asia Pacific
    • Middle East
      • By Product Type:
        • Reagents & Consumables
        • Instruments
      • By Application:
        • Disease Diagnostics
        • Molecular Diagnostics
        • Drug Development
      • By End User:
        • Hospitals
        • Clinical Laboratories
        • Academic & Research Institutes
        • Others
      • By Country:
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • By Product Type:
        • Reagents & Consumables
        • Instruments
      • By Application:
        • Disease Diagnostics
        • Molecular Diagnostics
        • Drug Development
      • By End User:
        • Hospitals
        • Clinical Laboratories
        • Academic & Research Institutes
        • Others
      • By Country/Region:
        • South Africa
        • Central Africa
        • North Africa
  • Company Profiles
    • Luminex Corporation *
      • Company Overview
      • Material Portfolio
      • Financial Performance
      • Key Highlights
      • Market Strategies
    • Thermo Fisher
    • Illumine Inc.
    • Bio-Rad Laboratories, Inc.
    • Qiagen N.V.
    • Abbott Laboratories
    • Siemens Healthineers
    • Agilent technologies
    • BioMerieux SA
    • Hoffmann-La Roche Ltd.

 “*” marked represents similar segmentation in other categories in the respective section.

Table of Contents

  1. Research Objectives and Assumptions
    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview
    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snippet, By Product
      • Market Snippet, By Application
      • Market Snippet, By End User
      • Market Snippet, By Region
    • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
    • Regulatory Scenario
    • Industry Trend
    • Merger and Acquisitions
    • New Product Approvals/Launch
    • Promotion and Marketing Initiatives
    • PEST Analysis
  4. Global Multiplexed Diagnostic Market, By Product Type, 2016 – 2027, (US$ Mn)
    • Introduction
      • Market Share Analysis, 2019 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017 – 2027
      • Segment Trends
    • Reagents & Consumables
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Instruments
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
  5. Global Multiplexed Diagnostic Market, By Application, 2016 – 2027, (US$ Mn)
    • Introduction
      • Market Share Analysis, 2019 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017 – 2027
      • Segment Trends
    • Disease Diagnostics
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Molecular Diagnostics
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Drug Development
      • Introduction
      • Market Size and Forecast, and Y-O-Y Growth, 2016 – 2027, (US$ Mn)
  6. Global Multiplexed Diagnostic Market, By End User, 2016 – 2027, (US$ Mn)
    • Introduction
      • Market Share Analysis, 2019 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017 – 2027
      • Segment Trends
    • Hospital
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Clinical Laboratories
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Academic & Research Institutes
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Others
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
  7. Global Multiplexed Diagnostic Market, By Region, 2016 – 2027, (US$ Mn)
    • Introduction
      • Market Share Analysis, By Region, 2019 and 2027 (%)
      • Y-o-Y Growth Analysis, For Regions, 2017–2027
    • North America
      • Market Size and Forecast, By Product, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Application, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By End User, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
        • U.S.
        • Canada
    • Latin America
      • Market Size and Forecast, By Product, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Application, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By End User, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe
      • Market Size and Forecast, By Product, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Application, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By End User, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
        • Germany
        • U.K.
        • France
        • Italy
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Market Size and Forecast, By Product, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Application, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By End User, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
        • China
        • India
        • Japan
        • Australia
        • South Korea
        • ASEAN
        • Rest of Asia Pacific
    • Middle East
      • Market Size and Forecast, By Product, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Application, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By End User, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • Market Size and Forecast, By Product, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Application, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By End User, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Country/Region, 2016 – 2027, (US$ Mn)
        • South Africa
        • Central Africa
        • North Africa
  8. Competitive Landscape
    • Heat Map Analysis
    • Market Share Analysis
      • Luminex Corporation
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Thermo Fisher Scientific, Inc.
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Illumine, Inc.
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Bio-Rad Laboratories, Inc.
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Qiagen N.V.
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Abbott Laboratories
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Siemens Healthineers
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Agilent technologies
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • BioMerieux SA
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Hoffmann-La Roche Ltd
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
    • Analyst Views
  9. Section
    • References
    • Research Methodology
    • About Us and Sales Contact

*Browse 54 market data tables and 35 figures on "Multiplexed Diagnostic Market” - Global forecast to 2027.

Frequently Asked Questions

This report provides in-depth analysis of the global multiplexed diagnostics market and provides market size (US$ Mn) and compound annual growth rate (CAGR) (%) for the forecast period (2019 – 2027). The report also provides also provides valuable insights about market drivers, restraints, opportunities, country outlook, and competitive strategies adopted by the leading players.
Key segments covered in the report include: product type, application type, end user, and region
The report provides also provides valuable insights about market drivers, restraints, opportunities, country outlook, and competitive strategies adopted by the leading players.
Increasing incidence of disease outbreaks, increasing incidence of chronic diseases, and increasing product launches and approvals.
The report profiles leading players in the global multiplexed diagnostics market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, key developments, and future plans.
The report profiles leading players in the global multiplexed diagnostics market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, key developments, and future plans.
Existing Clientele

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients

Our Trusted Patner